For the Inventor, By the Inventor

Enter assignee name

Sandvika, Norway

Algipharma as

USPTO Granted Patents = 12

% Expired Patents = 8.3

CIPO Patents = 2

EPO Patents = 13

Forward Citations = 25

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Arne Dessen (9 out of 11 patents)

Rolf Myrvold (6 out of 10 patents)

Philip Rye (5 out of 5 patents)

4. Edvar Onsoyen (5 out of 5 patents)

5. David Thomas (3 out of 5 patents)

6. Timothy Rutland Walsh (3 out of 4 patents)

7. Bildad Nyambura (1 out of 3 patents)

8. Astrid Hilde Myrset (1 out of 1 patent)

9. Paul Lewis (1 out of 2 patents)

10. Edvar Onsøyen (1 out of 1 patent)

11. Anand Bakle (1 out of 1 patent)

12. Are Kristiansen (1 out of 1 patent)

13. Stephen Hart (1 out of 1 patent)

14. Aristides Tagalakis (1 out of 1 patent)

15. Havard Sletta (4 patents)

12 patents: Sort by Forward Citations

1. 12649000 - Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers (2026-06-09),

2. 11992553 - Inhalable powder formulations of alginate oligomers (2024-05-28),

3. 11712448 - Use of alginate oligomers as blood anticoagulants (2023-08-01),

4. 11413306 - Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract (2022-08-16),

5. 11385174 - Method for the qualitative and quantitative detection of alginate oligomers in body fluids (2022-07-12),

6. 10751363 - Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunction (2020-08-25),

7. 10624920 - Use of alginate oligomers in combating biofilms (2020-04-21),

8. 9877983 - Use of alginate oligomers in combating biofilms (2018-01-30),

9. 9801901 - Alginate oligomers for use in overcoming multidrug resistance in bacteria (2017-10-31),

10. 9018158 - Alginate oligomers for use in overcoming multidrug resistance in bacteria (2015-04-28),

11. 8815831 - Treatment of Acinetobacter with alginate oligomers and antibiotics (2014-08-26),

12. 8680072 - Use of alginate oligomers in combating biofilms (2014-03-25),

Algipharma is a leading pharmaceutical company dedicated to developing innovative personalized medicine solutions. With a focus on precision medicine, Algipharma aims to provide tailored therapeutic options for patients with complex medical conditions. Through cutting-edge research and development, Algipharma is committed to improving patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

12 Patents

#2 in Sandvika

#143 in Norway

#48,036 in the World

Sandvika, Norway

Algipharma as

Forward Citations = 25

16 inventors:

Arne Dessen (9 out of 11 patents)

Rolf Myrvold (6 out of 10 patents)

Philip Rye (5 out of 5 patents)

4. Edvar Onsoyen (5 out of 5 patents)

5. David Thomas (3 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…